Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
Neuro-inflammatory processes that contribute to development of Alzheimer’s are evident early in the latent prodromal phase and worsen during the course of the disease. Despite substantial mechanistic and clinical evidence of inflammation, therapeutic approaches targeting inflammation have failed to alter the course of the disease. Disparate results from epidemiological and clinical trials targeting inflammation, highlight the complexity of the inflammatory process. Herein we review the dynamics of the inflammatory process across aging, midlife endocrine transitions, and the APOEε4 genotype and their contribution to progression of Alzheimer’s disease (AD). We discuss the chronic inflammatory processes that are activated during midlife chronological and endocrine aging, which ultimately limit the clearance capacity of microglia and lead to immune senescence. Aging, menopause, and APOEε4 combine the three hits of a compromised bioenergetic system of menopause with the chronic low grade innate inflammation of aging with the APOEε4 dyslipidemia and adaptive immune response. The inflammatory immune response is the unifying factor that bridges across each of the risk factors for AD. Immune system regulators that are specific to stage of disease and inflammatory phenotype would provide a therapeutic strategy to disconnect the bridge that drives disease. Outcomes of this analysis provide plausible mechanisms underlying failed clinical trials of anti-inflammatory agents in Alzheimer...
;import{g as i,s as o,r as s,e as a,a as u,h as l,b as c,i as h,t as f,c as d,d as p,f as m,j as g,k as y,l as b,K as v,_ as w,S as E,m as _,o as C,w as M,n as S,p as O,q as B,u as D,v as I,x as T,y as x,z as R,A as N,G as k,J as F,B as L,C as P,X as U,D as j,E as q,F as z,H as $,I as V,L as H,M as W,N as G,O as K,P as Z,Q as Y,R as J,T as X,U as Q,V as AA,W as eA,Y as tA,Z as rA,$ as nA,a0 as iA,a1 as oA,a2 as sA,a3 as aA,a4 as uA,a5 as lA,a6 as cA,a7 as hA,a8 as fA,a9 as dA,aa as pA,ab as mA,ac as gA,ad as yA,ae as bA,af as vA,ag as wA,ah as EA,ai as _A,aj as CA,ak as MA,al as SA,am as OA}fr
Explore this link on the map →saved by
related reading
- Frontiers | Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportfrontiersin.org
- Frontiers | A Bayesian model for chronic painfrontiersin.org
- Frontiers | Principles and Practice of Explainable Machine Learningfrontiersin.org
- Frontiers | Why Harmless Sensations Might Hurt in Individuals with Chronic Pain: About Heightened Prediction and Perception of Pain in the Mindfrontiersin.org
- Frontiers | Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Diseasefrontiersin.org
- Frontiers | Breastfeeding experiences and women's self-concept: Negotiations and dilemmas in the transition to motherhoodfrontiersin.org
- Frontiers | Simulating Emotions: An Active Inference Model of Emotional State Inference and Emotion Concept Learningfrontiersin.org
- Frontiers | The Role of NK Cells and Innate Lymphoid Cells in Brain Cancerfrontiersin.org
- Frontiers | Organic Molecules in Interstellar Space: Latest Advancesfrontiersin.org
- Frontiers | On the Cost of Knowledge: Evaluating the Boycott against Elsevierfrontiersin.org
- Frontiers | The Intense World Theory – A Unifying Theory of the Neurobiology of Autismfrontiersin.org
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org